Cited by 1,048Frailty in Older AdultsNutrition and Health in AgingPharmaceutical Practices and Patient Outcomes

The prevalence and outcomes of frailty in older cancer patients: a systematic review

Open access
Handforth, C., Clegg, A., Young, C., Simpkins, S., Seymour, M.T., Selby, P.J., Young, J.·2015·Annals of Oncology

Abstract

Background Frailty is a state of vulnerability to poor resolution of homeostasis following a stressor event, such as chemotherapy or cancer surgery. Better knowledge of the epidemiology of frailty could help drive a global cancer care strategy for older people. The aim of this review was to establish the prevalence and outcomes of frailty and pre-frailty in older cancer patients.Methods Observational studies that reported data on the prevalence and/or outcomes of frailty in older cancer patients with any stage of solid or haematological malignancy were considered. We searched Medline, CINAHL, Cochrane Library, EMBASE, Web of Science, Allied and Complementary medicine, Psychinfo and ProQuest (1 January 1996 to 30 June 2013). The primary outcomes were prevalence of frailty, treatment-related side-effects, unplanned hospitalization and mortality. Risk of bias was assessed using the Newcastle-Ottawa checklist.Results Data from 20 studies evaluating 2916 participants are included. The median reported prevalence of frailty and pre-frailty was 42% (range 6%-86%) and 43% (range 13%-79%), respectively. A median of 32% (range 11%-78%) of patients were classified as fit. Frailty was independently associated with increased all-cause mortality [adjusted 5-year hazard ratio (HR) 1.87, 95% confidence interval (CI) 1.36-2.57]. There was evidence of increased risk of postoperative mortality for both frailty (adjusted 30-day HR 2.67, 95% CI 1.08-6.62) and pre-frailty (adjusted HR 2.33, 95% CI 1.20-4.52). Treatment complications were more frequent in those with frailty, including intolerance to cancer treatment (adjusted odds ratio 4.86, 95% CI 2.19-10.78) and postoperative complications (adjusted 30-day HR 3.19, 95% CI 1.68-6.04).Conclusions More than half of older cancer patients have pre-frailty or frailty and these patients are at increased risk of chemotherapy intolerance, postoperative complications and mortality. The findings of this review support routine assessment of frailty in older cancer patients to guide treatment decisions, and the development of multidisciplinary geriatric oncology services.

Integrity signals

Registry

Crossref · 10.1093/annonc/mdu540

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Handforth, C., Clegg, A., Young, C., Simpkins, S., Seymour, M. T., Selby, P. J., & Young, J.
Affiliations
  • Leeds Teaching Hospitals NHS Trust (GB)
  • University of Leeds (GB)
Corresponding author
Handforth, C.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2015-06
Volume
26
Issue
6
Pages
1091-1101
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2159230388
Cited by
1,048
References
43
Citations by year
2026: 105 · 2025: 118 · 2024: 151 · 2023: 128 · 2022: 137 · 2021: 108 · 2020: 72 · 2019: 67 · 2018: 49 · 2017: 53 · 2016: 41 · 2015: 16 · 2014: 1 · 2012: 1
FWCI
3.16
Type
journal article
Language
en
Open access
Locations
  • Annals of Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
National Institute for Health and Care Research (NF-SI-0509-10020)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
frailty, pre-frailty, elderly cancer patients, frailty prevalence, all-cause mortality, postoperative mortality, chemotherapy intolerance, treatment side effects, postoperative complications, frailty assessment, geriatric oncology, hematologic malignancies, solid tumors, multidisciplinary care, frailty screening, frailty interventions, quality of life, functional status
MeSH terms
Age Factors, Aged, Aged, 80 and over, Antineoplastic Agents, Female, Humans, Male, Neoplasms, Postoperative Complications, Predictive Value of Tests, Risk Factors, Geriatric Assessment, Comorbidity, Prevalence, Odds Ratio, Frail Elderly, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review